# Study of Single and Multiple Doses of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Healthy Subjects

> **NCT00709254** · PHASE1 · COMPLETED · sponsor: **YM BioSciences** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** i.v. fentanyl
- **DRUG:** 3 mL AeroLEF (500 µg/1 mL)
- **DRUG:** 3 mL AeroLEF (500 µg/1 mL)

## Key facts

- **NCT ID:** NCT00709254
- **Lead sponsor:** YM BioSciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2002-01
- **Final completion:** 2002-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2008-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709254, "Study of Single and Multiple Doses of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00709254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*